Answers are grounded in this paper and cite their sources.
Clinical study demonstrates the persistence and role of HLA-DQ antibodies in transplant recipients, highlighting their influence on graft function and desensitization requirements.
Our study results showed that the class II HLA-DQ tissue group and anti-HLA antibodies against it play an important role in reducing the need for desensitization therapy and maintaining graft tissue functionality.
No takes yet. Share an insight, caveat, or question.
Üney et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: